Results 91 to 100 of about 10,033 (195)

Lokalisierte Sklerodermie (Morphea) im Kindesalter [PDF]

open access: yes, 2018
Zusammenfassung: Die lokalisierte (oder zirkumskripte) Sklerodermie (LS) oder Morphea ist eine sklerosierende Bindegewebserkrankung der Haut, die auch darunterliegende Gewebe wie Subkutis, Muskulatur und Skelett betreffen kann.
Weibel, L.
core  

Consensus-based recommendations for the management of juvenile localised scleroderma [PDF]

open access: yes, 2019
In 2012, a European initiative called Single Hub and Access point for paediatric Rheumatology in Europe (SHARE) was launched to optimise and disseminate diagnostic and management regimens in Europe for children and young adults with rheumatic diseases ...
Anton, Jordi   +18 more
core   +4 more sources

Bronchiolitis obliterans. [PDF]

open access: yes, 1989
Bronchiolitis obliterans in the adult patient is a relatively uncommon and vexing clinical entity. This confusion results because this pathologic finding occurs in a variety of diverse clinical settings.
King, TE
core  

Sexing the X: How the X Became the “Female Chromosome” [PDF]

open access: yes, 2014
This essay examines how the X became the “female chromosome” and how the association of the X with femaleness influences research questions, models, and descriptive language in human sex chromosome research.
Richardson, Sarah S
core   +2 more sources

Exploring the Association of Sociodemographic Factors and Primary Diagnosis With Transition Readiness in Adolescents With Rheumatic Disease

open access: yesACR Open Rheumatology, Volume 7, Issue 5, May 2025.
Objective Transitioning from pediatric to adult care is challenging for adolescents with chronic health conditions. The Transition Readiness Assessment Questionnaire (TRAQ) is a validated tool for measuring transition readiness in pediatric patients with chronic diseases.
Maryem Al Manaa   +6 more
wiley   +1 more source

The Role of Abatacept on Inflammation and Fibrosis in Hypochlorous Acid‐Induced Fibrosis Mice

open access: yesInternational Journal of Rheumatic Diseases, Volume 28, Issue 5, May 2025.
ABSTRACT Aim To investigate the effect of abatacept in the hypochlorous acid (HCLO)‐induced fibrosis model and to analyze changes in immune cell fractions within the abatacept‐treated early diffuse systemic sclerosis (SSc) cohort. Methods Fibrosis was induced in BALB/c mice by subcutaneous injection of HCLO, and abatacept was injected intraperitoneally
Bingying Dai   +14 more
wiley   +1 more source

Disabling pansclerotic morphea of childhood with extracutaneous manifestations

open access: yesIndian Journal of Dermatology, 2013
Disabling pansclerotic morphea (DPM) of childhood is a rare generalized type of localized scleroderma (LS) that is known to follow an aggressive course with pansclerotic lesions leading to severe joint contractures and consequent immobility. Mortality is
Mahendra M Kura, Saurabh R Jindal
doaj   +1 more source

Регуляторные пептиды в лечении склеродермии у женщин [PDF]

open access: yes, 2013
Досліджено ефективність препарату Імфламафертин у комплексній терапії хворих на обмежену склеродермію (ОСД). Представлено результати клінічного та лабораторного дослідження та спостереження 14 жінок, хворих на ОСД.
Горбунцов, В.В.   +3 more
core  

Diverse potential of chimeric antigen receptor‐engineered cell therapy: Beyond cancer

open access: yesClinical and Translational Medicine, Volume 15, Issue 4, April 2025.
1. In theory, CAR‐engineering therapy can achieve therapeutic effects by targeting cells expressing specific antigens and thereby eliminating or regulating disease‐related cell subpopulations. 2. Although CAR‐engineering therapy is currently only approved for the treatment of cancer, it has also shown potential in non‐tumour diseases. 3.
Lvying Wu, Lingfeng Zhu, Jin Chen
wiley   +1 more source

Prior elicitation of the efficacy and tolerability of Methotrexate and Mycophenolate Mofetil in Juvenile Localised Scleroderma [version 1; peer review: 2 approved] [PDF]

open access: yes, 2021
Background: Evidence is lacking for safe and effective treatments for juvenile localised scleroderma (JLS). Methotrexate (MTX) is commonly used first line and mycophenolate mofetil (MMF) second line, despite a limited evidence base. A head to head trial
Anderson, Marina E   +20 more
core  

Home - About - Disclaimer - Privacy